The low molecular weight heparin market is expected to grow from US$ 3,658.27 million in 2021 to US$ 5,733.96 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028.
Low molecular weight heparin (LMWH) is a class of anticoagulants. They are used to prevent blood clots and to treat venous thromboembolism (deep vein thrombosis and pulmonary embolism) and treat myocardial infarction. LMWHs are defined as heparin salts with an average molecular weight of less than 8,000 Da and in which at least 60% of all chains have a molecular weight of less than 8,000 Da. These are obtained by various methods of fractionation or depolymerization of polymeric heparin. Low molecular weight heparin offers advantages over heparin in that it has better bioavailability and longer half-life, simplified dosing, predictable anticoagulant response, lower risk of HIT, and lower risk of osteoporosis. With a longer half-life and a more predictable anticoagulant response, LMWH can be administered subcutaneously once or twice daily without coagulation monitoring, even when the drug is administered in treatment doses. Most patients do not require coagulation monitoring with LMWH. Key factors driving the growth of the market are the advantages of low molecular weight heparin over unfractionated heparin and the introduction of LMWH anticoagulants across the globe. However, the adverse effects of low molecular weight heparin during treatment hinder the market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Low Molecular Weight Heparin Market: Strategic Insights
Market Size Value in US$ 3,658.27 million in 2021 Market Size Value by US$ 5,733.96 million by 2028 Growth rate CAGR of 6.6% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Low Molecular Weight Heparin Market: Strategic Insights
| Market Size Value in | US$ 3,658.27 million in 2021 |
| Market Size Value by | US$ 5,733.96 million by 2028 |
| Growth rate | CAGR of 6.6% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The low molecular weight heparin market, by region, is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SAM). North America held the largest market share in 2021. The market in the region is expected to grow at the fastest pace during the forecast period. Major factors such as the growing burden of diseases, coupled with the rising geriatric population, and the rising number of approvals drive the market growth in the US. According to the Population Reference Bureau Factsheet, the number of Americans aged 65 years and above is projected to grow from 52 million in 2018 to 95 million by 2060, and the 65-and-above age group’s share of the total population is likely to rise from 16% to 23%. The geriatric population is more prone to chronic diseases. Therefore, the heparin market would grow significantly during the forecast period.
Lucrative Regions for Low Molecular Weight Heparin Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Advantages of Low Molecular Weight Heparin over Unfractionated Heparin
Low molecular weight heparins (LMWH) can be subcutaneously administered once a day without the need for any supervision. However, the effects of unfractionated heparin (UFH) or standard heparin vary from patient to patient. Therefore, it can only be administered to hospitalized patients under supervision. In addition, the LMWH has more predictable pharmacokinetic properties compared to unfractionated heparin, which allows its administration in fixed doses based on laboratory monitoring, without the need for dose adjustments.
The low molecular weight fractions of heparin have the molecular weight of ~3,500–8,000 Daltons, while unfractionated heparin has a molecular weight of 15,000 Daltons; thus, the former react less with platelets than the latter. Moreover, the LMWH is less likely to induce immune allergic thrombocytopenia, which is a severe side effect of unfractionated heparin (UFH). This condition is often complicated by arterial thrombosis. In addition, properties such as better bioavailability, predictable dose-response, and longer plasma half-life than unfractionated heparin make low molecular weight heparin a preferred choice for anticoagulation therapy. Such advantages of the LMWH over unfractionated heparin are boosting its demand, thereby spurring market growth.
Product Type-Based Insights
The global low molecular weight heparin market, based on product type, is segmented into enoxaparin, dalteparin, tinzaparin, fraxiparine, nadroparin, and others. The enoxaparin segment held the largest share of the market in 2021. However, the dalteparin segment is anticipated to register the highest CAGR in the market during the forecast period.
Low Molecular Weight Heparin Market, by Product Type – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Packaging-Based Insights
The global low molecular weight heparin market, based on packaging, is bifurcated into multi-vials and prefilled syringes. In 2021, the multi-vials segment held a larger share of the market. However, the prefilled syringes segment is expected to register a higher CAGR during 2021–2028.
Application-Based Insights
The global low molecular weight heparin market, based on application, is segmented into deep vein thrombosis, acute coronary syndrome (ACS), pulmonary embolism, and others. The deep vein thrombosis segment held the largest share of the market in 2021. However, the acute coronary syndrome (ACS) segment is anticipated to register the highest CAGR in the market during the forecast period.
End Use-Based Insights
The global low molecular weight heparin market, based on end user, has been segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2021. However, the ambulatory surgical centers segment is anticipated to register the highest CAGR in the market during the forecast period.
The low molecular weight heparin market players adopt organic strategies, such as product launch and expansion, to expand their footprint and product portfolio worldwide and to meet the growing demand.
Market by Geography
Geographically, the low molecular weight heparin market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).
COVID Impacts
The spread of the COVID-19 pandemic has emphasized health data sharing and interoperability under the microscope. The infection of novel coronavirus in children is mild compared to adults, and children are assigned a better prognosis. The interruptions in the supply chain and the massive demand for efficient treatments for COVID-19 have put the health research industry in Asia-Pacific in a crucial position.
Company Profiles
- Aspen Holdings
- Changzhou Qianhong Bio-Pharma
- Leopharma A/S
- Teva Pharmaceutical Industries Ltd.
- B. Braun Medical, Inc.
- Pfizer, Inc.
- Sanofi
- Dr. Reddy's Laboratories Limited
- Abbott
- Novartis AG
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type, Packaging, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Low Molecular Weight Heparin Market – By Product
1.3.2 Global Low Molecular Weight Heparin Market – By Packaging
1.3.3 Global Low Molecular Weight Heparin Market – By Application
1.3.4 Global Low Molecular Weight Heparin Market – By End User
1.3.5 Global Low Molecular Weight Heparin Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Low Molecular Weight Heparin Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Low Molecular Weight Heparin Market– Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact Analysis
6. Low Molecular Weight Heparin Market– Global Analysis
6.1 Global Low Molecular Weight Heparin Market Revenue Forecast and Analysis
6.2 Global Low Molecular Weight Heparin Market Revenue Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Low Molecular Weight Heparin Market Revenue and Forecast To 2028– By Product Type
7.1 Overview
7.2 Global Low Molecular Weight Heparin Market, By Product Type, 2021 & 2028 (%)
7.3 Enoxaparin
7.3.1 Overview
7.3.2 Enoxaparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
7.4 Dalteparin
7.4.1 Overview
7.4.2 Dalteparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
7.5 Nadroparin
7.5.1 Overview
7.5.2 Nadroparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
7.6 Fraxiparine
7.6.1 Overview
7.6.2 Fraxiparine: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
7.7 Tinzaparin
7.7.1 Overview
7.7.2 Tinzaparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
8. Low Molecular Weight Heparin Market Revenue and Forecast To 2028 – Packaging
8.1 Overview
8.2 Global Low Molecular Weight Heparin Market Share by Packaging - 2021 & 2028 (%)
8.3 Multi-Vials
8.3.1 Overview
8.3.2 Multi-Vials: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
8.4 Prefilled Syringes
8.4.1 Overview
8.4.2 Prefilled Syringes: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
9. Global Low Molecular Weight Heparin Market Revenue and Forecast To 2028– By Application
9.1 Overview
9.2 Global Low Molecular Weight Heparin Market, By Application, 2021 & 2028 (%)
9.3 Deep Vein Thrombosis
9.3.1 Overview
9.3.2 Deep Vein Thrombosis: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
9.4 Acute Coronary Syndrome (ACS)
9.4.1 Overview
9.4.2 Acute Coronary Syndrome (ACS): Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
9.5 Pulmonary Embolism
9.5.1 Overview
9.5.2 Pulmonary Embolism: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
10. Global Low Molecular Weight Heparin Market Revenue and Forecast To 2028– By End User
10.1 Overview
10.2 Global Low Molecular Weight Heparin Market, By End User, 2021 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
10.5 Ambulatory Surgical Centers
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
11. Low Molecular Weight Heparin Market Revenue and Forecast to 2028 – Geographical Analysis
11.1 North America: Low Molecular Weight Heparin Market
11.1.1 Overview
11.1.2 North America: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3 North America: Low Molecular Weight Heparin Market, by Product Type, 2019–2028 (US$ Million)
11.1.4 North America: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (US$ Million)
11.1.5 North America: Low Molecular Weight Heparin Market, by Application, 2019–2028 (US$ Million)
11.1.6 North America: Low Molecular Weight Heparin Market, by End Use, 2019–2028 (US$ Million)
11.1.7 North America: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)
11.1.7.1 US: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 US: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2 US: Low Molecular Weight Heparin Market, by Product Type, 2019–2028 (US$ Million)
11.1.7.1.3 US: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (US$ Million)
11.1.7.1.4 US: Low Molecular Weight Heparin Market, by Application, 2019–2028 (US$ Million)
11.1.7.1.5 US: Low Molecular Weight Heparin Market, by End Use, 2019–2028 (US$ Million)
11.1.7.2 Canada: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 Canada: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2 Canada: Low Molecular Weight Heparin Market, by Product Type, 2019–2028 (US$ Million)
11.1.7.2.3 Canada: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (US$ Million)
11.1.7.2.4 Canada: Low Molecular Weight Heparin Market, by Application, 2019–2028 (US$ Million)
11.1.7.2.5 Canada: Low Molecular Weight Heparin Market, by End Use, 2019–2028 (US$ Million)
11.1.8 Mexico: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.8.1 Mexico: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.8.2 Mexico: Low Molecular Weight Heparin Market, by Product Type, 2019–2028 (US$ Million)
11.1.8.3 Mexico: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (US$ Million)
11.1.8.4 Mexico: Low Molecular Weight Heparin Market, by Application, 2019–2028 (US$ Million)
11.1.8.5 Mexico: Low Molecular Weight Heparin Market, by End Use, 2019–2028 (US$ Million)
11.2 Europe: Low Molecular Weight Heparin Market Revenue and Forecast to 2028
11.2.1 Overview
11.2.2 Europe: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Mn)
11.2.3 Europe Low Molecular Weight Heparin Market Revenue and Forecast to 2028, By Product Type(US$ Mn)
11.2.4 Europe: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (USD Million)
11.2.5 Europe: Low Molecular Weight Heparin Market, by Application, 2019–2028 (USD Million)
11.2.6 Europe: Low Molecular Weight Heparin Market, by End Use, 2019–2028 (USD Million)
11.2.7 Europe Low Molecular Weight Heparin Market Revenue and Forecast to 2028, By Country (%)
11.2.7.1 Germany Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Mn)
11.2.7.1.1 Germany Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Mn)
11.2.7.1.2 Germany Low Molecular Weight Heparin Market Revenue and Forecast to 2028, By Product Type(US$ Mn)
11.2.7.1.3 Germany: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (USD Million)
11.2.7.1.4 Germany: Low Molecular Weight Heparin Market, by Application, 2019–2028 (US$ Million)
11.2.7.1.5 Germany: Low Molecular Weight Heparin Market, by End Use, 2019–2028 (US$ Million)
11.2.7.2 France Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Mn)
11.2.7.2.1 France: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.2.2 France Low Molecular Weight Heparin : Market, By Product Type, 2019–2028 (USD Million)
11.2.7.2.3 France: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (USD Million)
11.2.7.2.4 France: Low Molecular Weight Heparin Market, by Application, 2019–2028 (USD Million)
11.2.7.2.5 France: Low Molecular Weight Heparin Market, by End Use, 2019–2028 (USD Million)
11.2.7.3 UK: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.3.1 UK: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.3.2 UK: Low Molecular Weight Heparin Market, By Product Type, 2019–2028 (USD Million)
11.2.7.3.3 UK: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (USD Million)
11.2.7.3.4 UK: Low Molecular Weight Heparin Market, by Application, 2019–2028 (USD Million)
11.2.7.3.5 UK: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (USD Million)
11.2.7.4 Italy: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.4.1 Italy: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.4.2 Italy: Low Molecular Weight Heparin Market, By Product Type, 2019–2028 (USD Million)
11.2.7.4.3 Italy: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (USD Million)
11.2.7.4.4 Italy: Low Molecular Weight Heparin Market, by Application, 2019–2028 (USD Million)
11.2.7.4.5 Italy: Low Molecular Weight Heparin Market, by End Use, 2019–2028 (USD Million)
11.2.7.5 Spain: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.5.1 Spain: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.5.2 Spain: Low Molecular Weight Heparin Market, By Product Type, 2019–2028 (USD Million)
11.2.7.5.3 Spain: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (USD Million)
11.2.7.5.4 Spain: Low Molecular Weight Heparin Market, by Application, 2019–2028 (USD Million)
11.2.7.5.5 Spain: Low Molecular Weight Heparin Market, by End Use, 2019–2028 (USD Million)
11.2.7.6 Rest of Europe: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.6.1 Rest of Europe: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.6.2 Rest of Europe: Low Molecular Weight Heparin Market, By Product Type, 2019–2028 (USD Million)
11.2.7.6.3 Rest of Europe: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (USD Million)
11.2.7.6.4 Rest of Europe: Low Molecular Weight Heparin Market, by Application, 2019–2028 (USD Million)
11.2.7.6.5 Rest of Europe: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (USD Million)
11.3 Asia Pacific: Low Molecular Weight Heparin Market
11.3.1 Overview
11.3.2 Asia Pacific: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Low Molecular Weight Heparin Market, By Product Type, 2019–2028 (USD Million)
11.3.4 Asia Pacific: Low Molecular Weight Heparin Market, By Packaging, 2019–2028 (USD Million)
11.3.5 Asia Pacific: Low Molecular Weight Heparin Market, By Application, 2019–2028 (USD Million)
11.3.6 Asia Pacific: Low Molecular Weight Heparin Market, by End User, 2019–2028 (USD Million)
11.3.7 Asia Pacific: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)
11.3.7.1 China: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.1 China: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.2 China: Low Molecular Weight Heparin Market, By Product type, 2019–2028 (USD Million)
11.3.7.1.3 China: Low Molecular Weight Heparin Market, By Packaging, 2019–2028 (USD Million)
11.3.7.1.4 China: Low Molecular Weight Heparin Market, By Application, 2019–2028 (USD Million)
11.3.7.1.5 China: Low Molecular Weight Heparin Market, by End User, 2019–2028 (USD Million)
11.3.7.2 Japan: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.1 Japan: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.2 Japan: Low Molecular Weight Heparin Market, By Product type, 2019–2028 (USD Million)
11.3.7.2.3 Japan: Low Molecular Weight Heparin Market, By Packaging, 2019–2028 (USD Million)
11.3.7.2.4 Japan: Low Molecular Weight Heparin Market, By Application, 2019–2028 (USD Million)
11.3.7.2.5 Japan: Low Molecular Weight Heparin Market, by End User, 2019–2028 (USD Million)
11.3.7.3 India: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.1 India: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.2 India: Low Molecular Weight Heparin Market, By Product Type, 2019–2028 (USD Million)
11.3.7.3.3 India: Low Molecular Weight Heparin Market, By Packaging, 2019–2028 (USD Million)
11.3.7.3.4 India: Low Molecular Weight Heparin Market, By Application, 2019–2028 (USD Million)
11.3.7.3.5 India: Low Molecular Weight Heparin Market, by End User, 2019–2028 (USD Million)
11.3.7.4 Australia: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.1 Australia: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.2 Australia: Low Molecular Weight Heparin Market, By Product type, 2019–2028 (USD Million)
11.3.7.4.3 Australia: Low Molecular Weight Heparin Market, By Packaging, 2019–2028 (USD Million)
11.3.7.4.4 Australia: Low Molecular Weight Heparin Market, By Application, 2019–2028 (USD Million)
11.3.7.4.5 Australia: Low Molecular Weight Heparin Market, by End User, 2019–2028 (USD Million)
11.3.7.5 South Korea: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.1 South Korea: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.2 South Korea: Low Molecular Weight Heparin Market, By Product type, 2019–2028 (USD Million)
11.3.7.5.3 South Korea: Low Molecular Weight Heparin Market, By Packaging, 2019–2028 (USD Million)
11.3.7.5.4 South Korea: Low Molecular Weight Heparin Market, By Application, 2019–2028 (USD Million)
11.3.7.5.5 South Korea: Low Molecular Weight Heparin Market, by End User, 2019–2028 (USD Million)
11.3.7.6 Rest of Asia Pacific: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.1 Rest of Asia Pacific: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.2 Rest of Asia Pacific: Low Molecular Weight Heparin Market, By Product type, 2019–2028 (USD Million)
11.3.7.6.3 Rest of Asia Pacific: Low Molecular Weight Heparin Market, By Packaging, 2019–2028 (USD Million)
11.3.7.6.4 Rest of Asia Pacific: Low Molecular Weight Heparin Market, By Application, 2019–2028 (USD Million)
11.3.7.6.5 Rest of Asia Pacific: Low Molecular Weight Heparin Market, by End User, 2019–2028 (USD Million)
11.4 Middle East & Africa: Low Molecular Weight Heparin Market
11.4.1 Overview
11.4.2 Middle East & Africa: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
11.4.3 Middle East & Africa Low Molecular Weight Heparin Market, by Product type – Revenue and Forecast to 2028 (USD Million)
11.4.4 Middle East & Africa Low Molecular Weight Heparin Market, by Packaging – Revenue and Forecast to 2028 (USD Million)
11.4.5 Middle East & Africa Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (USD Million)
11.4.6 Middle East & Africa Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.4.7 Middle East & Africa: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)
11.4.7.1 Saudi Arabia: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.1.1 Saudi Arabia: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.2 Saudi Arabia Low Molecular Weight Heparin Market, by Product type – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.3 Saudi Arabia Low Molecular Weight Heparin Market, by Packaging – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.4 Saudi Arabia Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.5 Saudi Arabia Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.4.7.2 UAE: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.1 UAE: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.2 UAE Low Molecular Weight Heparin Market, by Product type – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.3 UAE Low Molecular Weight Heparin Market, by Packaging – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.4 UAE Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.5 UAE Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.4.7.3 South Africa: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.1 South Africa: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.2 South Africa Low Molecular Weight Heparin Market, by Product type – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.3 South Africa Low Molecular Weight Heparin Market, by Packaging – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.4 South Africa Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.5 South Africa Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.4.7.4 Rest of Middle East and Africa: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.4.1 Rest of Middle East and Africa: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.4.2 Rest of Middle East & Africa Low Molecular Weight Heparin Market, by Product type – Revenue and Forecast to 2028 (USD Million)
11.4.7.4.3 Rest of Middle East & Africa Low Molecular Weight Heparin Market, by Packaging – Revenue and Forecast to 2028 (USD Million)
11.4.7.4.4 Rest of Middle East & Africa Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (USD Million)
11.4.7.4.5 Rest of Middle East & Africa Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.5 South and Central America: Low Molecular Weight Heparin Market
11.5.1 Overview
11.5.2 South and Central America: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (USD Million)
11.5.3 South and Central America Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)
11.5.4 South and Central America Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
11.5.5 South and Central America Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
11.5.6 South and Central America Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.5.7 South and Central America: Low Molecular Weight Heparin Market Share by Country – 2021 & 2028, (%)
11.5.7.1 Brazil: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (USD Million)
11.5.7.1.1 Brazil: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (USD Million)
11.5.7.1.2 Brazil Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.3 Brazil Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.4 Brazil Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.5 Brazil Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.5.7.2 Argentina: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (USD Million)
11.5.7.2.1 Argentina: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (USD Million)
11.5.7.2.2 Argentina Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.3 Argentina Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.4 Argentina Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.5 Argentina Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.5.7.3 Rest of South and Central America: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.1 Rest of South and Central America: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.2 Rest of South and Central America Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.3 Rest of South and Central America Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.4 Rest of South and Central America Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.5 Rest of South and Central America Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)
12. Impact of COVID-19 Pandemic on Global Low Molecular Weight Heparin Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Low Molecular Weight Heparin Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Low Molecular Weight Heparin Market (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Abbott
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Novartis AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Sanofi
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Pfizer Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 B. Braun Medical Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Dr. Reddy's Laboratories
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 LEO Pharma A/S
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Aspen Holdings
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Changzhou Qianhong Biopharma Co Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Low Molecular Weight Heparin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (USD Million)
Table 3. North America Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Low Molecular Weight Heparin Market, by End Use, – Revenue and Forecast to 2028 (USD Million)
Table 5. US Low Molecular Weight Heparin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. US: Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (US$ Million)
Table 7. US: Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. US: Low Molecular Weight Heparin Market, by End Use – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: Low Molecular Weight Heparin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada: Low Molecular Weight Heparin Market, by End Use – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico: Low Molecular Weight Heparin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico: Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico: Low Molecular Weight Heparin Market, by End Use – Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe Low Molecular Weight Heparin Market Revenue and Forecast to 2028, By Product Type (US$ Mn).
Table 18. Europe Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (USD Million)
Table 19. Europe Low Molecular Weight Heparin Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 20. Europe Low Molecular Weight Heparin Market, by End Use – Revenue and Forecast to 2028 (USD Million)
Table 21. Germany Low Molecular Weight Heparin Market Revenue and Forecast to 2028, By Product Type(US$ Mn)
Table 22. Germany Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (USD Million)
Table 23. Germany: Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany: Low Molecular Weight Heparin Market, by End Use – Revenue and Forecast to 2028 (US$ Million)
Table 25. France: Low Molecular Weight Heparin Market, By Product Type– Revenue and Forecast to 2028 (USD Million)
Table 26. France Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (USD Million)
Table 27. France Low Molecular Weight Heparin Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 28. France Low Molecular Weight Heparin Market, by End Use – Revenue and Forecast to 2028 (USD Million)
Table 29. UK: Low Molecular Weight Heparin Market, By Product Type– Revenue and Forecast to 2028 (USD Million)
Table 30. UK Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (USD Million)
Table 31. UK: Low Molecular Weight Heparin Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 32. UK: Low Molecular Weight Heparin Market, By Packaging– Revenue and Forecast to 2028 (USD Million)
Table 33. Italy: Low Molecular Weight Heparin Market, By Product Type– Revenue and Forecast to 2028 (USD Million)
Table 34. Italy Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (USD Million)
Table 35. Italy Low Molecular Weight Heparin Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 36. Italy Low Molecular Weight Heparin Market, by End Use – Revenue and Forecast to 2028 (USD Million)
Table 37. Spain: Low Molecular Weight Heparin Market, By Product Type– Revenue and Forecast to 2028 (USD Million)
Table 38. Spain Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (USD Million)
Table 39. Spain Low Molecular Weight Heparin Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 40. Spain Low Molecular Weight Heparin Market, by End Use – Revenue and Forecast to 2028 (USD Million)
Table 41. Rest of Europe: Low Molecular Weight Heparin Market, By Product Type– Revenue and Forecast to 2028 (USD Million)
Table 42. Rest of Europe Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (USD Million)
Table 43. Rest of Europe Low Molecular Weight Heparin Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 44. Rest of Europe Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (USD Million)
Table 45. Asia Pacific: Low Molecular Weight Heparin Market, By Product Type – Revenue and Forecast to 2028 (USD Million)
Table 46. Asia Pacific: Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
Table 47. Asia Pacific: Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 48. Asia Pacific Low Molecular Weight Heparin Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 49. China: Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 50. China: Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
Table 51. China: Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 52. China: Low Molecular Weight Heparin Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 53. Japan: Low Molecular Weight Heparin Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 54. Japan: Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
Table 55. Japan: Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 56. Japan: Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 57. India: Low Molecular Weight Heparin Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 58. India: Low Molecular Weight Heparin Market, By Packaging– Revenue and Forecast to 2028 (USD Million)
Table 59. India: Low Molecular Weight Heparin Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 60. India: Low Molecular Weight Heparin Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 61. Australia: Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 62. Australia: Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
Table 63. Australia: Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 64. Australia: Low Molecular Weight Heparin Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 65. South Korea: Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 66. South Korea: Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
Table 67. South Korea: Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 68. South Korea: Low Molecular Weight Heparin Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Asia Pacific: Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 70. Rest of Asia Pacific: Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
Table 71. Rest of Asia Pacific: Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 72. Rest of Asia Pacific: Low Molecular Weight Heparin Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 73. Middle East & Africa Low Molecular Weight Heparin Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 74. Middle East & Africa Low Molecular Weight Heparin Market, by Packaging – Revenue and Forecast to 2028 (USD Million)
Table 75. Middle East & Africa Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 76. Middle East & Africa Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 77. Saudi Arabia Low Molecular Weight Heparin Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 78. Saudi Arabia Low Molecular Weight Heparin Market, by Packaging – Revenue and Forecast to 2028 (USD Million)
Table 79. Saudi Arabia Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 80. Saudi Arabia Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 81. UAE Low Molecular Weight Heparin Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 82. UAE Low Molecular Weight Heparin Market, by Packaging – Revenue and Forecast to 2028 (USD Million)
Table 83. UAE Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 84. UAE Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 85. South Africa Low Molecular Weight Heparin Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 86. South Africa Low Molecular Weight Heparin Market, by Packaging – Revenue and Forecast to 2028 (USD Million)
Table 87. South Africa Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 88. South Africa Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Middle East & Africa Low Molecular Weight Heparin Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Middle East & Africa Low Molecular Weight Heparin Market, by Packaging – Revenue and Forecast to 2028 (USD Million)
Table 91. Rest of Middle East & Africa Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 92. Rest of Middle East & Africa Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 93. South and Central America Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 94. South and Central America Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
Table 95. South and Central America Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 96. South and Central America Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 97. Brazil Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 98. Brazil Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
Table 99. Brazil Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 100. Brazil Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 101. Argentina Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 102. Argentina Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
Table 103. Argentina Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 104. Argentina Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 105. Rest of South and Central America Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 106. Rest of South and Central America Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)
Table 107. Rest of South and Central America Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 108. Rest of South and Central America Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 109. Organic Developments in the Low Molecular Weight Heparin Market
Table 110. Inorganic Developments in the Low Molecular Weight Heparin Market
Table 111. Glossary of Terms, Low Molecular Wight Heparin Market
LIST OF FIGURES
Figure 1. Low Molecular Weight Heparin Market Segmentation
Figure 2. Low Molecular Weight Heparin Market, By Region
Figure 3. Global Low Molecular Weight Heparin Market Overview
Figure 4. Enoxaparin Segment Held Largest Share of Product Type Segment in Low Molecular Weight Heparin Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Low Molecular Weight Heparin Market, by Geography (US$ Million)
Figure 7. Global Low Molecular Weight Heparin Market- Leading Country Markets (US$ Million)
Figure 8. Global Low Molecular Weight Heparin Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Low Molecular Weight Heparin Market Impact Analysis of Driver and Restraints
Figure 16. Global Low Molecular Weight Heparin Market– Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Low Molecular Weight Heparin Market– Revenue Forecast and Analysis – 2021 & 2028
Figure 18. Market Positioning of Key Players in Global Low Molecular Weight Heparin Market
Figure 19. Global Low Molecular Weight Heparin Market, By Product Type, 2021 & 2028 (%)
Figure 20. Enoxaparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Dalteparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Nadroparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Fraxiparine: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Tinzaparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. Global LMWH Market Share by Packaging - 2021 & 2028 (%)
Figure 27. Multi-Vials: Low Molecular Weight Heparin Market Revenue and Forecast To 2028 (US$ Million)
Figure 28. Prefilled Syringes: Low Molecular Weight Heparin Market Revenue and Forecast To 2028 (US$ Million)
Figure 29. Global Low Molecular Weight Heparin Market, By Application, 2021 & 2028 (%)
Figure 30. Deep Vein Thrombosis: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. Acute Coronary Syndrome (ACS): Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. Pulmonary Embolism: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. Others: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. Global Low Molecular Weight Heparin Market, By End User, 2021 & 2028 (%)
Figure 35. Hospitals: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. Clinics: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. Ambulatory Surgical Centers: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. Others: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. North America: Low Molecular Weight Heparin Market, by Key Country – Revenue (2021) (US$ Million)
Figure 40. North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
Figure 41. North America: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)
Figure 42. US: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Canada: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Mexico: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Europe: Low Molecular Weight Heparin Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 46. Europe: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Mn)
Figure 47. Europe Low Molecular Weight Heparin Market Revenue and Forecast to 2028, By Country (%)
Figure 48. Germany Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Mn)
Figure 49. France: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. UK: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Italy: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 52. Spain: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 53. Rest of Europe: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 54. Asia Pacific: Low Molecular Weight Heparin Market, by Key Country – Revenue (2021) (USD Million)
Figure 55. Asia Pacific Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (USD Million)
Figure 56. Asia Pacific: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)
Figure 57. China: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Japan: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. India: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. Australia: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. South Korea: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. Rest of Asia Pacific: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. Middle East & Africa: Low Molecular Weight Heparin Market, by Key Country – Revenue (2021) (USD Million)
Figure 64. Middle East & Africa Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (USD Million)
Figure 65. Middle East & Africa: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)
Figure 66. Saudi Arabia: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. UAE: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 68. South Africa: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)
Figure 69. Rest of Middle East and Africa: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (USD Million)
Figure 70. South and Central America: Low Molecular Weight Heparin Market, By Key Country – Revenue (2021) (USD Million)
Figure 71. South and Central America: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (USD Million)
Figure 72. South and Central America: Low Molecular Weight Heparin Market Share by Country – 2021 & 2028, (%)
Figure 73. Brazil: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (USD Million)
Figure 74. Argentina: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (USD Million)
Figure 75. Rest of SCAM: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (USD Million)
Figure 76. Impact of COVID-19 Pandemic in North American Country Markets
Figure 77. Impact Of COVID-19 Pandemic in Europe Country Markets
Figure 78. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 79. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 80. Impact Of COVID-19 Pandemic in South & Central America Country Markets
The List of Companies - Low Molecular Weight Heparin Market
- Aspen Holdings
- Changzhou Qianhong Bio-pharma
- LEOPHARMA A/S
- Teva Pharmaceutical Industries Ltd.
- B. Braun Medical Inc.
- Pfizer Inc.
- Sanofi-Aventis
- Dr. Reddy's Laboratories Limited
- Abbott
- Novartis AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Low Molecular Weight Heparin Market
Dec 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Dec 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Dec 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Dec 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Dec 2021